Ladenburg Thalmann Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$73K Sell
754
-1,213
-62% -$117K ﹤0.01% 3253
2019
Q3
$158K Buy
1,967
+1,130
+135% +$90.8K ﹤0.01% 2633
2019
Q2
$61K Buy
837
+434
+108% +$31.6K ﹤0.01% 3319
2019
Q1
$37K Hold
403
﹤0.01% 3604
2018
Q4
$29K Buy
403
+103
+34% +$7.41K ﹤0.01% 3639
2018
Q3
$27K Buy
+300
New +$27K ﹤0.01% 3703
2018
Q1
Sell
-225
Closed -$29K 5095
2017
Q4
$29K Sell
225
-326
-59% -$42K ﹤0.01% 3561
2017
Q3
$65K Sell
551
-35
-6% -$4.13K ﹤0.01% 2908
2017
Q2
$47K Buy
586
+225
+62% +$18K ﹤0.01% 3066
2017
Q1
$18K Sell
361
-515
-59% -$25.7K ﹤0.01% 3613
2016
Q4
$33K Sell
876
-219
-20% -$8.25K ﹤0.01% 3138
2016
Q3
$75K Sell
1,095
-2,399
-69% -$164K ﹤0.01% 2456
2016
Q2
$194K Buy
3,494
+2,853
+445% +$158K ﹤0.01% 1702
2016
Q1
$41K Buy
641
+215
+50% +$13.8K ﹤0.01% 2733
2015
Q4
$40K Buy
426
+100
+31% +$9.39K ﹤0.01% 2726
2015
Q3
$26K Sell
326
-27
-8% -$2.15K ﹤0.01% 2922
2015
Q2
$42K Sell
353
-53
-13% -$6.31K ﹤0.01% 2702
2015
Q1
$42K Sell
406
-133
-25% -$13.8K ﹤0.01% 2680
2014
Q4
$52K Buy
539
+239
+80% +$23.1K ﹤0.01% 2335
2014
Q3
$23K Hold
300
﹤0.01% 2530
2014
Q2
$19K Hold
300
﹤0.01% 2694
2014
Q1
$20K Sell
300
-100
-25% -$6.67K ﹤0.01% 2563
2013
Q4
$26K Hold
400
﹤0.01% 2358
2013
Q3
$26K Sell
400
-900
-69% -$58.5K ﹤0.01% 2262
2013
Q2
$40K Buy
+1,300
New +$40K ﹤0.01% 1870